Not Signed In - New Spine Fusion Indication for Recombinant Protein Treatment
Tue, 19 Apr 2005 09:00 AM EST
... Wyeth and Astellas BV, today announced that the European Commission has approved InductOs™ (rhBMP-2/ACS) [recombinant human Bone Morphogenetic Protein-2/Absorbable Collagen Sponge] for the treatment of single level (L4-S1) anterior lumbar spine fusions as a substitute for autogenous bone graft in adults with degenerative disc disease who have had at least six months of nonoperative treatment for this condition... click link for more info. ...
Related Topics
- Neck Disorders and Injuries
- Factor IX
- Protein C
- Dietary Proteins
- Protein S
- Total Protein
- Egg Protein
- Malnutrition
- Osteoarthritis
- Treatment
- Spine
- Curvature of the spine
- Epoetin Alfa Injection
- Mitochondrial trifunctional protein deficiency
- Back Pain
- Treatments
- Factor V Leiden thrombophilia
- Worsening range of movement in the spine, elbows, and hands
- Scoliosis
- Electrophoresis
email this page
print this page
bookmark this page
feedback on this page
